VANCOUVER, British Columbia, April 23, 2019 /CNW/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE: SNN) (OTCQB: SNNVF), a North American provider of cannabis products and services plans to release its results for the fourth quarter and fiscal year 2018 and provide a corporate update on its Canadian and US operations, after market close on Monday April 29, 2019.

The Company's executive management will discuss the results during a conference call on Tuesday, April 30, 2019 at 11:00 am Eastern Time / 8:00 am Pacific Time. To participate in the call please dial 1-800-319-4610, or (604) 638-5340. An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674-8052 and entering code 3178. The replay will be available for two weeks following the call.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world's two largest cannabis markets – California and Canada. Sunniva is focused on creating sustainable premium cannabis brands supported by our large-scale, purpose-built cGMP designed greenhouse and extraction facilities. We offer a steadfast commitment to safety and quality assurance providing cannabis products free from pesticides, which uniquely positions Sunniva in California as a leading provider of safe, high quality, reproducible products at scale. Through production from Phase One of our strategically positioned 325,000 square foot high technology greenhouse which is nearing completion and our fully operational extraction facility in California, we are launching Sunniva branded products in various product categories and price points including flower, pre-rolls, vape cartridges and premium concentrates. Sunniva branded products will be showcased within our flagship dispensary located at the greenhouse and our in-house marketing and distribution team will ensure the placement of Sunniva branded products at licensed dispensaries throughout the state. Sunniva's management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law, including, but not limited to, statements relating to the completion of Phase One of the greenhouse, the Company's launch of Sunniva branded products in various product categories and price points including flower, pre-rolls, vape cartridges and premium concentrates, the showcase of Sunniva branded products within the Company's flagship dispensary located at the Sunniva California Campus and the placement of Sunniva branded products at licensed dispensaries throughout the state of California. Forward looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Company Contacts:





Sunniva Inc.

Dr. Anthony Holler

Chairman and Chief Executive Officer

Phone: (866) 786-6482





Investor Contact: Media Contact: Phil Carlson / Erika Kay Katelyn Tumino / Tony Forde KCSA Strategic Communications KCSA Strategic Communications Phone: (212) 896-1233 Phone: (212) 896-1252 Email: [email protected] / [email protected] Email: [email protected] / [email protected]

SOURCE Sunniva Inc.